Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin - PubMed (original) (raw)

Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin

P S Piraino et al. J Neuroimmunol. 2002 Oct.

Abstract

CNS leukocytic invasion in experimental allergic encephalomyelitis (EAE) depends on alpha4beta1 integrin/vascular cell adhesion molecule-1 (VCAM-1) interactions. A small molecule inhibitor of alpha4beta1 integrin (CT301) was administered to guinea pigs in the chronic phase (>d40) of EAE for 10, 20, 30 or 40 days. CT301 elicited a rapid, significant improvement in the clinical and pathological scores that was maintained throughout the treatment period. A progressive loss of cells in the spinal cord of treated animals confirmed the resolution of inflammation associated with clinical recovery. Therefore, prolonged inhibition of alpha4beta1 integrin caused a sustained reversal of disease pathology in chronic EAE and may be similarly useful in MS.

PubMed Disclaimer

Similar articles

• Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of alpha4 integrin.
  Piraino PS, Yednock TA, Freedman SB, Messersmith EK, Pleiss MA, Karlik SJ. Piraino PS, et al. Mult Scler. 2005 Dec;11(6):683-90. doi: 10.1191/1352458505ms1223oa. Mult Scler. 2005. PMID: 16320728
• Apoptotic cells are present in the CNS throughout acute and chronic-progressive EAE in the absence of clinical recovery.
  Hyduk SJ, Karlik SJ. Hyduk SJ, et al. J Neuropathol Exp Neurol. 1998 Jun;57(6):602-14. doi: 10.1097/00005072-199806000-00007. J Neuropathol Exp Neurol. 1998. PMID: 9630239
• A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis.
  Kent SJ, Karlik SJ, Cannon C, Hines DK, Yednock TA, Fritz LC, Horner HC. Kent SJ, et al. J Neuroimmunol. 1995 Apr;58(1):1-10. doi: 10.1016/0165-5728(94)00165-k. J Neuroimmunol. 1995. PMID: 7730443
• Spontaneous remyelination following prolonged inhibition of alpha4 integrin in chronic EAE.
  Piraino PS, Yednock TA, Messersmith EK, Pleiss MA, Freedman SB, Hammond RR, Karlik SJ. Piraino PS, et al. J Neuroimmunol. 2005 Oct;167(1-2):53-63. doi: 10.1016/j.jneuroim.2005.06.018. J Neuroimmunol. 2005. PMID: 16095724
• The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications.
  Sheremata WA, Minagar A, Alexander JS, Vollmer T. Sheremata WA, et al. CNS Drugs. 2005;19(11):909-22. doi: 10.2165/00023210-200519110-00002. CNS Drugs. 2005. PMID: 16268663 Review.

Cited by

• Adhesion molecules in CNS disorders: biomarker and therapeutic targets.
  Ma Q, Chen S, Klebe D, Zhang JH, Tang J. Ma Q, et al. CNS Neurol Disord Drug Targets. 2013 May 1;12(3):392-404. doi: 10.2174/1871527311312030012. CNS Neurol Disord Drug Targets. 2013. PMID: 23469854 Free PMC article. Review.
• Anti-integrin therapy for multiple sclerosis.
  Kawamoto E, Nakahashi S, Okamoto T, Imai H, Shimaoka M. Kawamoto E, et al. Autoimmune Dis. 2012;2012:357101. doi: 10.1155/2012/357101. Epub 2012 Dec 17. Autoimmune Dis. 2012. PMID: 23346387 Free PMC article.
• Molecular MRI enables early and sensitive detection of brain metastases.
  Serres S, Soto MS, Hamilton A, McAteer MA, Carbonell WS, Robson MD, Ansorge O, Khrapitchev A, Bristow C, Balathasan L, Weissensteiner T, Anthony DC, Choudhury RP, Muschel RJ, Sibson NR. Serres S, et al. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6674-9. doi: 10.1073/pnas.1117412109. Epub 2012 Mar 26. Proc Natl Acad Sci U S A. 2012. PMID: 22451897 Free PMC article.
• Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
  Constantinescu CS, Farooqi N, O'Brien K, Gran B. Constantinescu CS, et al. Br J Pharmacol. 2011 Oct;164(4):1079-106. doi: 10.1111/j.1476-5381.2011.01302.x. Br J Pharmacol. 2011. PMID: 21371012 Free PMC article. Review.
• alpha4-Integrin antagonism with natalizumab: effects and adverse effects.
  Stüve O, Gold R, Chan A, Mix E, Zettl U, Kieseier BC. Stüve O, et al. J Neurol. 2008 Dec;255 Suppl 6:58-65. doi: 10.1007/s00415-008-6011-0. J Neurol. 2008. PMID: 19300961 Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal